分享好友 资讯首页 频道列表

Philip Morris Asia Limited Comments on Tribunal’s Decision to Decline Jurisdiction in Arbitration Ag

2015-12-18 11:0115980

Ruling Does Not Address Legality of Trademark Ban Under International Law

HONG KONG -- (BUSINESS WIRE) --

Philip Morris Asia Limited (PMAL), a Hong Kong company that is the parent of Philip Morris Australia, said today that an arbitral tribunal has declined jurisdiction to hear the merits of PMAL’s case against the Commonwealth of Australia under Australia’s 1993 Investment Promotion and Protection Agreement (IPPA) with Hong Kong.

“There is nothing in today’s outcome that addresses, let alone validates, plain packaging in Australia or anywhere else,” said Marc Firestone, Philip Morris International Senior Vice President and General Counsel. “It is regrettable that the outcome hinged entirely on a procedural issue that Australia chose to advocate instead of confronting head on the merits of whether plain packaging is legal or even works”.

PMAL filed its claims under the IPPA on November 21, 2011, when the Australian government passed plain packaging legislation. PMAL asserted that the sweeping ban on trademarks breaches the foreign investment protections that the Australian government guaranteed in its IPPA with Hong Kong.

Firestone continued, “This case has never been about a government’s undeniable authority to regulate in the public interest. Nor has there ever been any question that tobacco products merit strict oversight. In our view, the real point is simply this: Even when pursuing tobacco control objectives, governments are still accountable if they choose to use unlawful means. This is the essence of the rule of law.”

The Australian government’s tobacco packaging policy remains the subject of international disagreement. The World Trade Organization (WTO) is currently considering challenges to Australia's legislation by four WTO Members. Separately, courts in Europe are also assessing plain packaging under national and international law. The decision on jurisdiction under the Australia-Hong Kong IPPA has no bearing on any of these proceedings.

Australia’s former Labor government made bold promises regarding the public health benefits that its excessive, expropriatory trademark ban -- which it labeled a policy experiment – would yield. Three years into the experiment, data from a range of sources consistently demonstrate that the promised outcomes are not being delivered.

PMAL is reviewing the Tribunal’s decision in detail and will determine any further course of action.

###

Philip Morris International Inc.

Philip Morris International Inc. (PMI) is the leading international tobacco company, with six of the world’s top 15 international brands, including Marlboro, the number one cigarette brand worldwide. PMI’s products are sold in more than 180 markets. In 2014, the company held an estimated 15.5% share of the total international cigarette market outside of the U.S., or 28.5% excluding the People’s Republic of China and the U.S. For more information, see www.pmi.com.

Philip Morris Asia Limited

Philip Morris Asia Limited (PMAL) manages PMI’s business in the Asia region. PMA is based in Hong Kong where the company was incorporated under the Hong Kong Companies Ordinance in 1994. PMAL owns the Australian affiliate, Philip Morris Limited (PML).

Philip Morris Limited

Philip Morris Limited (PML) began operations in Australia in 1954 as the first affiliate outside of the United States. Based in Melbourne, PML employs more than 500 people and is the second largest distributor of cigarettes in Australia. PML sells a number of well-known brands, including Marlboro, Alpine, Longbeach, Peter Jackson and choice. In 2014, PML held an estimated 34% share of the Australian cigarette market.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151217006627/en/

 

CONTACT:

Media Enquiries
Philip Morris International media office
T: +41 (0)58 242 4500
E: media@pmi.com

反对 0
举报 0
收藏 0
打赏 0
评论 0
VIVERE Group選擇Rimini Street強化SAP支援,加速企業轉型
總部位於印尼的整合室內設計與家具解決方案供應商,藉由專業SAP支援,取得更大的自主權與強大執行能力,以自身節奏推動企業轉型 拉斯維加斯--(美國商業資訊)-- Rimini Street, Inc. (Nasdaq: RMNI)是提供軟體支援與Agentic AI ERP的公司™,也是Oracle、SAP與VMware軟體領先的第三方支援服務供應商。該公司今日宣布,印尼領先的一站式室內工程、家具製造及家居陳設解決方案供應商VIVERE Group已選擇採用Rimini Suppor...

0评论2026-07-161722

Agenus宣布最高达3.4亿美元的超额认购私募融资,以推进针对MSS结肠癌新辅助治疗方案BOT+BAL的ROBBIN注册性临床试验
预计8500万美元的前期融资,加上行权后最高可达2.55亿美元的认购权证资金,将用于资助Agenus针对微卫星稳定型(MSS)结肠癌的新辅助治疗药物博滕西利单抗(botensilimab)和巴尔斯利单抗(balstilimab)(BOT+BAL)的III期注册临床试验ROBBIN1, 该交易的结构旨在为Agenus提供资金,以支持其度过关键的价值转折点,包括中期核心病理缓解数据以及中期和最终无事件生存期(EFS)分析;假设认股权证被全部行权,所得款项将用于支持Agenus的运营直至2031...

0评论2026-07-161648

L&T Technology Services与Anthropic达成合作,为产品和制造领域提供AI驱动的工程智能
核心亮点: LTTS加入Claude合作伙伴网络,将Claude模型整合至其工程智能平台,包括AgenticIQ、PlxAI、Ainfonix、AiNexus和AiTest LTTS利用Claude帮助企业客户重塑工程工作流、加速创新并开拓新的收入机会 旧金山和印度班加罗尔--(美国商业资讯)--工程智能解决方案与工程研发(ER&D)咨询服务领域的全球领导者L&T Technology Services Limited (BSE: 540115, NSE: LTTS)今...

0评论2026-07-161835

Esri 助力 Google Maps 与 Waze 实时更新道路封闭信息
ArcGIS 用户现可将道路封闭信息共享至更多消费级导航应用,助力提升驾驶者出行体验 Esri 已扩展其社区地图计划,使 ArcGIS 用户能够直接向 Google Maps 和 Waze 共享实时道路封闭信息。 目前,全球已有超过 100 个社区通过 Esri 社区地图计划提供权威的道路封闭数据。 ArcGIS 道路封闭解决方案帮助政府部门绘制并发布因道路施工、大型活动及突发事件造成的道路封闭信息,并将其共享至消费级导航应用。 与 Waze for Cities 的集成实现了双...

0评论2026-07-161325

Neuraptive Therapeutics獲得聖路易華盛頓大學創新生物可吸收神經刺激技術授權
賓夕法尼亞州賈斯特布魯克--(美國商業資訊)--專注於周圍神經損傷治療的臨床階段生物科技公司Neuraptive Therapeutics, Inc.今日宣布,已與聖路易華盛頓大學(WashU)簽署獨家授權合約,獲得一項生物可吸收無線電子神經刺激裝置技術的獨家授權。 該技術由WashU醫學院研究人員與美國西北大學合作研發,可透過向受損神經精準輸送電脈波,加快神經再生。該裝置採用完全生物可吸收設計,可在人體內自然降解,無需接受後續手術進行取出。 WashU副校長兼技術管理辦公室董事總經...

0评论2026-07-161600

牛津经济研究院新研究揭示酒吧的社会与经济影响
该报告由AB InBev委托发布,探讨了世界各地的人们如何通过酒吧建立联系和构建社群 伦敦--(美国商业资讯)--根据牛津经济研究院(Oxford Economics)的最新研究,酒吧是全球各地社区重要的社会和经济贡献者。这项由AB InBev委托进行的研究考察了酒吧在五个全球市场——巴西、墨西哥、韩国、英国和美国——的经济和社会影响。 本新闻稿包含多媒体。此处查看新闻稿全文: https://www.businesswire.com/new...

0评论2026-07-161218

Kinaxis Inc.将于2026年8月6日召开2026年第二季度财报电话会议
渥太华,安大略省--(美国商业资讯)--端到端供应链规划与协调领域的全球领先企业 Kinaxis® Inc.(TSX:KXS)今日宣布,公司已安排召开电话会议,以讨论截至2026年6月30日的第二季度财务业绩。本次电话会议将于2026年8月6日星期四东部时间上午8:30举行,由首席执行官Razat Gaurav和财务规划与分析副总裁Peter Yaraskavitch主持,随后将进行问答环节。公司将于2026年8月5日星期三股市收盘后公布第二季度财务业绩。 ...

0评论2026-07-161895

European Commission Approves Erbitux (cetuximab) in Combination with Encorafenib and FOLFOX for First-Line Treatment of Metastatic Colorectal Cancer with BRAF V600E Mutation
ERBITUX in combination with encorafenib and FOLFOX is the first and only approved targeted regimen for the first-line treatment of adult patients with BRAF V600E-mutant mCRC The approval is based on the pivotal Phase 3 BREAKWATER trial, which demonst...

0评论2026-07-161830

Clearlake Capital Announces Partnership with Databricks to Advance AI-Enabled Investing and Portfolio Value Creation
Partnership combines the Databricks platform with West Monroe's implementation expertise to help Clearlake build an “investment firm of the future” data platform across deal origination, due diligence, fund operations, and portfolio company transfor...

0评论2026-07-161068

Takeda and the Indonesian Government Announce Landmark Collaboration to Strengthen Healthcare Resilience and Expand Access to Lifesaving Plasma-Derived Medicinal Products
Ministry of Health of the Republic of Indonesia Grants Plasma Fractionation License, Enabling Takeda to Collect and Fractionate Plasma as Part of Multi-Phased Initiative Takeda Will Initially Invest up to 30 Million U.S. Dollars to Begin the Establis...

0评论2026-07-161023